Data / Form D filings / MUSTANG BIO, INC.
MUSTANG BIO, INC.: Form D filings
MUSTANG BIO, INC., a biotechnology company in Worcester, MA, filed 9 Form D notices with the SEC between 2016 and 2024. The latest, on June 24, 2024, reports $2.5 million sold of a $2.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 377 PLANTATION STREET, Worcester, MA, 01605
- Phone
- (781) 652-4500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1680048
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | New notice | $2,513,139 | $2,513,139 | 1 | Jun 19, 2024 | sec.gov | |
| Nov 3, 2023 | New notice | $4,742,942 | $4,742,942 | 1 | Oct 26, 2023 | sec.gov | |
| Apr 12, 2017 | New notice | $416,000 | $416,000 | 7 | Mar 31, 2017 | sec.gov | |
| Feb 15, 2017 | Amendment | $100,000,000 | $94,585,711 | $5,414,289 | 1086 | Jan 31, 2017 | sec.gov |
| Jan 13, 2017 | Amendment | $70,000,000 | $39,096,680 | $30,903,320 | 519 | Dec 29, 2016 | sec.gov |
| Jan 13, 2017 | Amendment | $70,000,000 | $34,987,081 | $35,012,919 | 437 | Dec 12, 2016 | sec.gov |
| Dec 13, 2016 | Amendment | $70,000,000 | $31,886,581 | $38,113,419 | 390 | Nov 30, 2016 | sec.gov |
| Nov 4, 2016 | Amendment | $70,000,000 | $19,535,184 | $50,464,816 | 222 | Oct 25, 2016 | sec.gov |
| Oct 17, 2016 | New notice | $70,000,000 | $12,446,414 | $57,553,586 | 133 | Sep 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Manuel B. Litchman, M.D. | Executive Officer, Director | |
| Adam J. Chill | Director | |
| Michael J. Zelefsky, M.D. | Director | |
| James B Murphy | Executive Officer | |
| Neil A. Herskowitz | Director | |
| Lindsay A. Rosenwald, M.D. | Director | |
| Michael S. Weiss | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MUSTANG BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.